Proactive research analyst John Savin speaks to Thomas Warner after publishing a new research note on Voyageur Pharmaceuticals Ltd (TSX-V:VM, OTC:VYYRF), a Canadian company that specialises in transforming raw materials into pharmaceutical-grade contrast agents that can be used in medical imaging.
Savin gives a brief summary of the note, titled “Voyageur Pharmaceuticals: Earthly profits from contrasting media.”
#ProactiveInvestors #VoyageurPharmaceuticals #ContrastMedia #XRayEnhancement #MRIEnhancement #PharmaceuticalIndustry #VerticallyIntegratedCompany #MiningToPharmaceuticals #BariumProduction #IodineProduction #GreenCarbonProject #FDARegulatedProducts #HealthcareInnovation #MedicalImaging #CanadianCompany #ProactiveResearch #AnalystReport #MarketOpportunity #MedicalTechnology #DiagnosticImaging #HealthcareSolutions #PharmaceuticalDevelopment #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews
source